This second part of the article on porognostic and predictive markers in NSCLC addresses other potentially useful genes / proteins except tyrosine kinases that were described in the first part. There are mentioned genes with key pathways in tumor growth and metastasis as well as hormonal, epigenetic and immunohistochemical and proteomic mechanisms.
Special attention is also paid to markers associated with the prediction of immunotherapy and chemotherapy.